Skip to main content
Year archive

Heidelberg Pharma AG — 2012 filings

All 55 regulatory filings released by Heidelberg Pharma AG (HPHA) in 2012, sourced directly from the official regulator.

55 Filings
2012 Period
2012 filings (55)
Filing Released Lang
Declaration of Voting Results & Voting Rights Announcements 2012
Declaration of Voting Results & Voting Rights Announcements
2012-12-17 English
WILEX AG: WILEX Inc. signs distribution agreement with Immundiagnostik AG for D-A-CH region
Regulatory Filings
2012-12-12 English
WILEX AG announces restructuring
Regulatory Filings
2012-12-04 English
WILEX AG announces results of Phase III ARISER study with RENCAREX(R) in clear cell renal cell carcinoma
Regulatory Filings
2012-10-16 English
WILEX AG announces results of Phase III ARISER study with RENCAREX(R) in clear cell renal cell carcinoma
Earnings Release FY 2012
2012-10-16 English
WILEX AG publishes 9-months financial report 2012
Earnings Release 9M 2012
2012-10-11 English
Q3 Report 2011/2012
Interim / Quarterly Report 9M 2012
2012-10-11 German
WILEX AG and the FDA agree on the further development of REDECTANE(R)
Legal Proceedings Report
2012-10-05 English
Declaration of Voting Results & Voting Rights Announcements 2012
Declaration of Voting Results & Voting Rights Announcements
2012-09-05 English
Declaration of Voting Results & Voting Rights Announcements 2012
Declaration of Voting Results & Voting Rights Announcements
2012-09-03 English
Declaration of Voting Results & Voting Rights Announcements 2012
Declaration of Voting Results & Voting Rights Announcements
2012-09-03 English
WILEX AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2012-08-31 English
DGAP-DD: WILEX AG english
Director's Dealing
2012-08-30 English
DGAP-DD: WILEX AG english
Director's Dealing
2012-08-27 English
WILEX AG successfully completes combined capital increase of cash and contribution in kind totalling EUR 23.9 million
Capital/Financing Update
2012-08-24 English
WILEX AG announces planned change to Executive Management Board
Board/Management Information
2012-08-07 English
WILEX AG plans rights offering and combined capital increase of cash and contribution in kind
Capital/Financing Update
2012-08-03 English
WILEX AG reports on Oncologic Drugs Advisory Committee (ODAC) meeting and positive vote on diagnostic imaging
Legal Proceedings Report
2012-07-25 English
WILEX AG announces results of successful first half year 2012
Earnings Release H1 2012
2012-07-12 English
Q2 Report 2011/2012
Interim / Quarterly Report H2 2012
2012-07-12 English
6-Monatsbericht 2011/2012
Interim / Quarterly Report H2 2012
2012-07-12 German
WILEX AG opts for further payment under the licence agreement with Prometheus
Legal Proceedings Report
2012-07-06 English
Declaration of Voting Results & Voting Rights Announcements 2012
Declaration of Voting Results & Voting Rights Announcements
2012-07-06 English
DGAP-DD: WILEX AG english
Director's Dealing
2012-06-28 English
DGAP-DD: WILEX AG english
Director's Dealing
2012-06-28 English
DGAP-DD: WILEX AG english
Director's Dealing
2012-06-28 English
DGAP-DD: WILEX AG english
Director's Dealing
2012-06-28 English
DGAP-DD: WILEX AG english
Director's Dealing
2012-06-28 English
DGAP-DD: WILEX AG english
Director's Dealing
2012-06-28 English
DGAP-DD: WILEX AG english
Director's Dealing
2012-06-28 English
WILEX AG: MESUPRON(R) met its primary objective of demonstrating efficacy in the proof of concept phase II breast cancer trial
Regulatory Filings
2012-06-14 English
WILEX AG: MESUPRON(R) met its primary objective of demonstrating efficacy in the proof of concept phase II breast cancer trial
Legal Proceedings Report
2012-06-14 English
WILEX AG reports on Annual General Meeting 2012
AGM Information
2012-05-25 English
Wilex AG: Bekanntmachung der Einberufung zur Hauptversammlung am 25.05.2012 in Munchen mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2012-04-13 German
WILEX AG publishes financial report for the first quarter of 2012
Earnings Release Q1 2012
2012-04-12 English
Q1 Report 2011/2012
Interim / Quarterly Report Q1 2012
2012-04-12 German
WILEX AG starts first patient study with MEK inhibitor WX-554
Regulatory Filings
2012-04-11 English
WILEX AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2012-02-29 English
WILEX AG reports on a successful financial year 2011
Earnings Release FY 2011
2012-02-28 English
Annual Report 2010/2011
Annual Report FY 2011
2012-02-28 German
WILEX AG: FDA approves protocol amendment needed to conduct the final analysis of the pivotal RENCAREX(R) Phase III trial
Legal Proceedings Report
2012-02-27 English
Report Publication Announcement 2012
Report Publication Announcement
2012-02-15 English
DGAP-DD: WILEX AG english
Director's Dealing
2012-02-15 English
WILEX AG: WILEX Inc. appoints Walter Carney as CSO for the further development of Oncogene Science diagnostics
Board/Management Information
2012-02-15 English
DGAP-DD: WILEX AG english
Director's Dealing
2012-02-09 English
DGAP-DD: WILEX AG english
Director's Dealing
2012-02-09 English
DGAP-DD: WILEX AG english
Director's Dealing
2012-02-09 English
Declaration of Voting Results & Voting Rights Announcements 2012
Declaration of Voting Results & Voting Rights Announcements
2012-02-08 English
DGAP-DD: WILEX AG english
Director's Dealing
2012-02-07 English
DGAP-DD: WILEX AG english
Director's Dealing
2012-02-06 English
DGAP-DD: WILEX AG english
Director's Dealing
2012-02-06 English
WILEX AG receives funding from the German Federal Ministry of Education and Research for the development of WX-037 as part of the 'm4 cluster initiative'
Regulatory Filings
2012-02-06 English
WILEX AG successfully completes rights issue
Share Issue/Capital Change
2012-02-01 English
WILEX AG successfully completed Phase I study in Healthy Volunteers with the oral MEK inhibitor WX-554
Regulatory Filings
2012-01-18 English
WILEX AG resolves rights issue using authorised capital
Capital/Financing Update
2012-01-09 English